Correlation Between Moberg Pharma and BioArctic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Moberg Pharma and BioArctic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moberg Pharma and BioArctic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moberg Pharma AB and BioArctic AB, you can compare the effects of market volatilities on Moberg Pharma and BioArctic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moberg Pharma with a short position of BioArctic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moberg Pharma and BioArctic.

Diversification Opportunities for Moberg Pharma and BioArctic

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Moberg and BioArctic is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Moberg Pharma AB and BioArctic AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioArctic AB and Moberg Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moberg Pharma AB are associated (or correlated) with BioArctic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioArctic AB has no effect on the direction of Moberg Pharma i.e., Moberg Pharma and BioArctic go up and down completely randomly.

Pair Corralation between Moberg Pharma and BioArctic

Assuming the 90 days trading horizon Moberg Pharma AB is expected to under-perform the BioArctic. In addition to that, Moberg Pharma is 1.4 times more volatile than BioArctic AB. It trades about -0.05 of its total potential returns per unit of risk. BioArctic AB is currently generating about 0.02 per unit of volatility. If you would invest  22,680  in BioArctic AB on September 23, 2024 and sell it today you would lose (1,400) from holding BioArctic AB or give up 6.17% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Moberg Pharma AB  vs.  BioArctic AB

 Performance 
       Timeline  
Moberg Pharma AB 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Moberg Pharma AB are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental drivers, Moberg Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.
BioArctic AB 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BioArctic AB are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, BioArctic sustained solid returns over the last few months and may actually be approaching a breakup point.

Moberg Pharma and BioArctic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Moberg Pharma and BioArctic

The main advantage of trading using opposite Moberg Pharma and BioArctic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moberg Pharma position performs unexpectedly, BioArctic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioArctic will offset losses from the drop in BioArctic's long position.
The idea behind Moberg Pharma AB and BioArctic AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated